Table 2 Demographics and baseline characteristics of Chronic Heart Failure patients according to cognitive function (CI) n = 525
Overall | Normal | Cognitive impairment | n | p value | |
|---|---|---|---|---|---|
Demographics, n% | 525 | 380 (72) | 145 (28) | 525 | |
Age, years, mean (SD) | 71 (11) | 70 (11) | 75 (9) | 525 | <0.001 |
Female gender n (%) | 205 (39) | 126 (33) | 79 (55) | 525 | <0.001 |
NYHA class n% (I, II / III, IV) | 300 (59) / 211 (41) | 229 (62) / 139 (38) | 71 (50) / 72 (50) | 511 | 0.007 |
Heart rate > =70, bpm, n (%) | 304 (59) | 210 (56) | 94 (66) | 515 | 0.034 |
SBP, mean (SD) | 126 (22) | 126 (23) | 124 (21) | 517 | 0.324 |
Preserved LVEF %, mean (SD) | 180 (34) | 131 (34) | 49 (34) | 525 | 0.484 |
Aetiology of CHF, n% | 382 (73) | 268 (71) | 114 (79) | 520 | 0.042 |
Hypertension n% | 412 (79) | 295 (79) | 114 (79) | 520 | 0.459 |
Diabetes n% | 239 (47) | 162 (44) | 77 (54) | 511 | 0.023 |
Peripheral artery disease n% | 99 (19) | 63 (17) | 36 (25) | 521 | 0.020 |
CKD | 286 (55) | 195 (52) | 91 (63) | 523 | 0.014 |
Anaemia n% | 176 (33) | 120 (32) | 56 (39) | 525 | 0.078 |
Cerebrovascular disease n% | 62 (12) | 40 (11) | 22 (15) | 521 | 0.089 |
COPD n% | 114 (22) | 79 (21) | 35 (24) | 517 | 0.239 |
ACEI or ARBs n% | 426 (82) | 311 (83) | 115 (80) | 519 | 0.243 |
Betablockers n% | 482 (92) | 358 (95) | 124 (86) | 522 | 0.001 |
MRA n% | 228 (44) | 167 (44) | 61 (42) | 521 | 0.383 |
Nt-pro BNP n% | 248 (48) | 169 (45) | 79 (56) | 515 | 0.014 |
Albumin mean (SD) | 4 (0) | 4 (0) | 3.6 (0) | 501 | <0.001 |
Albumin < 3.5 | 97 (19) | 57 (16) | 40 (28) | 501 | 0.002 |
eGFR mean (SD) | 59 (22) | 60 (23) | 55 (21) | 523 | <0.017 |